Natco Pharma Ltd. (NATCOPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 156274,
    "name": "Natco Pharma",
    "stock_name": "Natco Pharma",
    "full_name": "Natco Pharma Ltd.",
    "name_url": "stocks-analysis/natco-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "790.00",
    "chg": -6,
    "chgp": "-0.75%",
    "dir": -1,
    "prev_price": "796.00",
    "mcapval": "15,517.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524816,
    "symbol": "NATCOPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE987B01026",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "2.69 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/natco-pharma-156274-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dividends, bonus issues: Last day to buy IGL, Natco Pharma among 7 stocks before record date",
        "link": "https://news.google.com/rss/articles/CBMiogJBVV95cUxPUkNHM0ZmNl9TUm9YNkZ5aFl6QVdkajk4QngwbGZZZGVsajVKSW5XcVdjeUFvMUg5eWJnN1hZXzQtZEFWeDJnUGo0d202TURoYkl5VThCZjI5clVGTEN3dW9jeHVzUzVBYzczUUtQcGIzWjctendWcjdPR2FkYzVnLWM0Z0xHZE8yQnNyUUprMmp0bVNVYWhkTUQxZVA5dnIweHhMdTR3ZnA2dW1HRkFOT2xMZW5ISFhGNHRWWDRtVW5Ld2Q5aVdyYTFXRU1SczVtZmt4c0psRFhROW5za0tjUTJ2QnVJVjJ3RDJOanNtMk9xUDFVdGt4WDNJckQ0SUJheVlpa2tQT0traXdaWUIyakl3QmNlRnoxOG43Q2kySHJvQQ?oc=5",
        "imagepath": "",
        "date": "2026-09-30 07:45:20",
        "description": "Dividends, bonus issues: Last day to buy IGL, Natco Pharma among 7 stocks before record date  The Economic Times..."
      },
      {
        "title": "Natco Pharma hikes investment in US-based eGenesis to $16.7 million",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-29 08:07:09",
        "description": "Natco Pharma hikes investment in US-based eGenesis to $16.7 million  Business Standard..."
      },
      {
        "title": "Natco Pharma raises eGenesis investment to $16.70 million",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-29 05:35:20",
        "description": "Natco Pharma raises eGenesis investment to $16.70 million  BusinessLine..."
      },
      {
        "title": "Natco Pharma board approves rights issue to raise up to 1,279 crore",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-25 14:05:39",
        "description": "Natco Pharma board approves rights issue to raise up to 1,279 crore  BusinessLine..."
      },
      {
        "title": "Natco Pharma looks beyond generics for its next growth shot",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-01 06:00:37",
        "description": "Natco Pharma looks beyond generics for its next growth shot  Livemint..."
      }
    ],
    "total": 5,
    "sid": "156274",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/natco-pharma-156274"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Oct-2026",
      "details": "News Paper Publications",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "30-Sep-2026",
      "details": "Proceedings of the 43rd Annual General Meting",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Sep-2026",
      "details": "Closure of Trading Window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 20 Aug 26",
          "dt": "2026-08-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15",
          "dt": "2015-11-26",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has announced <strong>2:21</strong> rights issue, ex-date: 01 Oct 26",
          "dt": "2026-10-01",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views